Best implant for patients, delivering significant savings

PRUDENT, PREDICTABLE AND TOLERANT HIP IMPLANTS Years of research and thousands of surgical hours…

READ MORE

Innovating processes –  optimised access to ORTHIMO®   Product Information

Innovating processes – optimised access to ORTHIMO® Product Information

As part of the ORTHIMO® vision to bring significant savings to stakeholder, ORTHIMO® is introducing customer focused digital product information. Today, almost all medical devices contain instruction booklets in redundant languages. Often these instructions are in small print, cumbersome to read and only available once the packaging seal has been…
NHS could save £120 million with Generic hip implants now available

NHS could save £120 million with Generic hip implants now available

The NHS could be set to deliver some of the savings set out in Lord Carter’s recent review of spending, with new devices introduced into the health system.  This week, generic hip implants have become available through the NHS Supply Chain. This ensures that NHS hospitals now have access to high quality, less expensive orthopaedic implants.…
Is orthopaedics ready to adopt generic implants?

Is orthopaedics ready to adopt generic implants?

Generics have been long established in pharmaceuticals, and are beginning to gain support in orthopaedics – we look at whether the UK is ready to adopt generic implants on a wider scale. At this year’s BOA Congress in Liverpool, experts debated the subject of generics in orthopaedics. The 90-minute symposium in front of 200 delegates included…
Meet the Team:  Jiří Pavlíček, Chief Commercial Officer

Meet the Team: Jiří Pavlíček, Chief Commercial Officer

Jiří Pavlíček, one of Orthimo’s co-founders and Chief Commercial Officer, began his working life as a mechanical engineer in the former Czechoslovakia in the early 1990’s. But an inspiring trip to the United States prompted his move to orthopaedics – an area that has enabled him to combine his love of both logical systems and human emotions. After…
Orthimo CEO, Luc Vangerven, Reflects on the BOA Conference

Orthimo CEO, Luc Vangerven, Reflects on the BOA Conference

Orthimo CEO, Luc Vangerven, Reflects on the BOA Conference This fall was a very exciting time for Orthimo.The British Orthopaedics Association (BOA) Congress is a major milestone in the UK orthopaedics calendar and this year marked the first appearance of Orthimo in the exhibition hall.   BOA is always a great event; a chance to catch up…
In depth interview: A trail blazed by generic medicines?

In depth interview: A trail blazed by generic medicines?

Katrina Megget, former Editor of PharmaTimes looks back to see how  generics transformed pharmaceuticals and how we have reached a point  today where 80% of medicines dispensed by the NHS are generic.  Generic (or non-proprietary) medicines have been part of the NHS since its  inception; and even before its foundation in…
Meet the team: Denis Pichon (CTO)

Meet the team: Denis Pichon (CTO)

In our first Meet the Team article, we introduce Chief Technology Officer for Orthimo, Denis Pichon. Denis began his career as a mechanical engineer, with a focus on and passion for orthopaedics. Name a job within orthopaedics, and Denis has almost certainly done it. He’s been an engineer, a product developer, a marketer and a general manager.…
Ethel Martindale, 84, a pioneering patient

Ethel Martindale, 84, a pioneering patient

Ethel Martindale, 84, lives independently in her home in Peterlee, County Durham – and is frequently visited by her four children, and eight grandchildren. A keen dancer, Ethel was a weekly attendee at her local ballroom dancing events, and it was here that Ethel first began noticing problems with her hips. Whilst initially there was no pain,…
Transforming orthopaedics - creating a new implant category

Transforming orthopaedics - creating a new implant category

Generics’ are a well-established concept in pharmaceuticals, with patients benefitting from high quality medicines, but at a better value proposition to economic stakeholders Orthimo is the first company to bring the concept of true generics to the field of Orthopaedic Implants. Evidence from over one million hip replacement operations in…
Implants with the best clinical outcome – proven by Registry data

Implants with the best clinical outcome – proven by Registry data

Research of long term data from leading national hip implant registers was used to identify the hip implant components with the best long term outcomes performance for patients. Overall, the registries contain data from over one million hip replacement operations. These were analyzed, both quantitatively and qualitatively, to find the high-volume…
Optimised Equivalence with branded reference products

Optimised Equivalence with branded reference products

 Optimised Equivalent® implants are precisely engineered implants with equivalence to the best performing cemented and cementless branded reference components.  The manufacturing of the Optimised Equivalent ® implants is done by highly established suppliers with many decades of experience in manufacturing orthopaedic implants, further…
Innovative modular services - data driven  business model

Innovative modular services - data driven business model

The key value based innovation is Orthimo’s modular services business model:  surgeons and hospitals can now choose which services are most appropriate for them. This is a distinct advantage over the branded, all inclusive higher price offering, and it will allow hospital units to achieve further cost savings and to either increase…
Follow us for more

Follow us for more

Orthimo is a fast growing organization changing the world of orthopedics. To stay tuned to our progress and receive our latest update, please fill the form below. We will contact you maximum once a month via email.